Daily
250 words
5/10
Rating

10 July 2026

NeoSep 1 trial for neonatal sepsis

The trial provides significant context for public health interventions regarding neonatal mortality in India, though it is a specific clinical study rather than a direct government policy or landmark legislation.

1 min read 2 questions 2 prelims

Notes

  • NeoSep 1 is an international clinical trial evaluating antibiotic combinations for neonatal sepsis.
  • The trial is sponsored by the GARDP Foundation in collaboration with UCL, SGUL, and the Penta Foundation.
  • The study aims to enrol 3,000 newborns across Asia and Africa by 2028.
  • Neonatal sepsis is a bloodstream infection in babies under 90 days old, often affecting premature or low-birth-weight infants.
  • Sepsis is the second most common cause of neonatal mortality globally, causing over one million deaths annually.
  • In India, neonatal sepsis accounts for 30%–40% of all neonatal deaths, resulting in approximately 2,00,000–2,50,000 preventable deaths annually.
  • Indian microbiological profiles differ from global trends: gram-negative organisms (Klebsiella pneumoniae, E. coli, Acinetobacter, Pseudomonas) predominate in India, whereas Group B Streptococcus is the leading cause in developed countries.
  • The trial uses a Personalised Randomised Controlled Trial (PRACTical) design to rank multiple antibiotic regimens.
  • Primary outcome of the study is death within 28 days; secondary outcomes include death within 90 days, length of hospital stay, and re-admission.

Questions

  1. Discuss the significance of the NeoSep 1 trial in addressing the challenge of antimicrobial resistance in neonatal care in India. 150 words
    Attempt this — 150 words in 8 min
    0 / 150 words 8:00
  2. Neonatal sepsis remains a leading cause of preventable mortality in India. Analyze the epidemiological challenges, including the divergence of causative pathogens from global trends, and the role of clinical trials in improving public health outcomes. 250 words
    Attempt this — 250 words in 11 min
    0 / 250 words 11:00

Prelims

  1. Which of the following best describes the primary objective of the NeoSep 1 trial?

  2. According to studies on neonatal sepsis in India, which group of organisms is primarily responsible for infections, differing from trends in developed countries?

Syllabus

Topics

Sources

250words.in · https://250words.in/daily/2026-07-10/neosep-1-trial-for-neonatal-sepsis